Tamsulosin as a Medical Expulsive Therapy for Ureteral Stones: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

坦索罗辛 医学 荟萃分析 随机对照试验 泌尿科 药物治疗 外科 内科学 增生
作者
Yu Cui,Jinbo Chen,Feng Zeng,Peihua Liu,Jiao Hu,Huihuang Li,Chao Li,Cheng Xu,Minfeng Chen,Yangle Li,Yang Li,Zhongqing Yang,Zhiyong Chen,Harripersaud Chand,Hequn Chen,Xiongbing Zu
出处
期刊:The Journal of Urology [Lippincott Williams & Wilkins]
卷期号:201 (5): 950-955 被引量:15
标识
DOI:10.1097/ju.0000000000000029
摘要

No AccessJournal of UrologyAdult Urology1 May 2019Tamsulosin as a Medical Expulsive Therapy for Ureteral Stones: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsThis article is commented on by the following:Editorial CommentEditorial Comment Yu Cui, Jinbo Chen, Feng Zeng, Peihua Liu, Jiao Hu, Huihuang Li, Chao Li, Xu Cheng, Minfeng Chen, Yangle Li, Yang Li, Zhongqing Yang, Zhiyong Chen, Harripersaud Chand, Hequn Chen, and Xiongbing Zu Yu CuiYu Cui Department of Urology, Xiangya Hospital, Central South University, Changsha, China Equal study contribution. More articles by this author , Jinbo ChenJinbo Chen Department of Urology, Xiangya Hospital, Central South University, Changsha, China Equal study contribution. More articles by this author , Feng ZengFeng Zeng Department of Urology, Xiangya Hospital, Central South University, Changsha, China More articles by this author , Peihua LiuPeihua Liu Department of Urology, Xiangya Hospital, Central South University, Changsha, China More articles by this author , Jiao HuJiao Hu Department of Urology, Xiangya Hospital, Central South University, Changsha, China More articles by this author , Huihuang LiHuihuang Li Department of Urology, Xiangya Hospital, Central South University, Changsha, China More articles by this author , Chao LiChao Li Department of Urology, Xiangya Hospital, Central South University, Changsha, China More articles by this author , Xu ChengXu Cheng Department of Urology, Xiangya Hospital, Central South University, Changsha, China More articles by this author , Minfeng ChenMinfeng Chen Department of Urology, Xiangya Hospital, Central South University, Changsha, China More articles by this author , Yangle LiYangle Li Department of Urology, Xiangya Hospital, Central South University, Changsha, China More articles by this author , Yang LiYang Li Department of Urology, Xiangya Hospital, Central South University, Changsha, China More articles by this author , Zhongqing YangZhongqing Yang Department of Urology, Xiangya Hospital, Central South University, Changsha, China More articles by this author , Zhiyong ChenZhiyong Chen Department of Urology, Xiangya Hospital, Central South University, Changsha, China More articles by this author , Harripersaud ChandHarripersaud Chand Department of Urology, Xiangya Hospital, Central South University, Changsha, China More articles by this author , Hequn ChenHequn Chen †Correspondence: Department of Urology, Xiangya Hospital, Central South University, Changsha410008, China (telephone: +86-731-8975-3011; FAX: +86-731-8975-3280; e-mail: E-mail Address: [email protected], E-mail Address: [email protected]). Department of Urology, Xiangya Hospital, Central South University, Changsha, China More articles by this author , and Xiongbing ZuXiongbing Zu †Correspondence: Department of Urology, Xiangya Hospital, Central South University, Changsha410008, China (telephone: +86-731-8975-3011; FAX: +86-731-8975-3280; e-mail: E-mail Address: [email protected], E-mail Address: [email protected]). Department of Urology, Xiangya Hospital, Central South University, Changsha, China More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000000029AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: Tamsulosin is widely administered as a medical expulsive therapy to facilitate stone passage in patients with ureteral calculi. Recently several large, multicenter, randomized controlled trials revealed conflicting results, which led to considerable uncertainty about the efficacy of tamsulosin in the management of ureteral stones. The objective of this systematic review and meta-analysis was to evaluate the efficacy and safety of tamsulosin in the management of ureteral stones. Materials and Methods: We searched MEDLINE®, Embase®, Web of Knowledge, Google Scholar™ and the Cochrane Central Search Library databases up to June 2018. Two reviewers independently evaluated eligible randomized controlled trials of the efficacy of tamsulosin to treat ureteral stones. Study quality was assessed with the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) system. Subgroup analyses were performed to explore heterogeneity. Results: Included in study were 56 randomized controlled trials in a total of 9,395 patients. The observed treatment effect indicated that tamsulosin was associated with a higher stone expulsion rate (RR 1.44, 95% CI 1.35-1.55, p <0.01), a shorter stone expulsion time (weighted mean difference –0.73, 95% CI –1.00-–0.45, p <0.01), a lesser incidence of ureteral colic (weighted mean difference –0.81, 95% CI –1.24-–0.39, p <0.01) and fewer incidences of requiring subsequent intervention (RR 0.68, 95% CI 0.50-0.93, p = 0.017). Treatment with tamsulosin did not differ from a control group in the overall incidence of side effects (RR 1.14, 95% CI 0.86-1.51, p = 0.36). On subgroup analysis we observed a significant benefit in the stone expulsion rate for tamsulosin among patients with stones greater than 5 mm (RR 1.44, 95% CI 1.22-1.68, p <0.01) but no effect for stones 5 mm or less (RR 1.08, 95% CI 0.99-1.68, p <0.01). Conclusions: Our current meta-analysis results indicate that tamsulosin is effective and relatively safe in patients with ureteral stone as a medical expulsive therapy to facilitate stone passage. It is suggested to administer it selectively in patients with 5 to 10 mm ureteral stones. References 1. : EAU guidelines on diagnosis and conservative management of urolithiasis. Eur Urol 2016; 69: 468. Google Scholar 2. : Trends in urological stone disease. BJU Int 2012; 109: 1082. Google Scholar 3. : The economics of stone disease. World J Urol 2017; 35: 1321. Google Scholar 4. : Cost-effectiveness of medical expulsive therapy using alpha-blockers for the treatment of distal ureteral stones. Eur Urol 2008; 53: 411. Google Scholar 5. : 2007 Guideline for the management of ureteral calculi. J Urol 2007; 178: 2418. Link, Google Scholar 6. : Tamsulosin for ureteral stones: a systematic review and meta-analysis of a randomized controlled trial. Urol Int 2012; 89: 107. Google Scholar 7. : Medical expulsive therapy in adults with ureteric colic: a multicentre, randomised, placebo-controlled trial. Lancet 2015; 386: 341. Google Scholar 8. : Effect of tamsulosin on passage of symptomatic ureteral stones: a randomized clinical trial. JAMA Intern Med 2018; 178: 1051. Google Scholar 9. : Distal ureteric stones and tamsulosin: a double-blind, placebo-controlled, randomized, multicenter trial. Ann Emerg Med 2016; 67: 86. Google Scholar 10. : Efficacy and safety of tamsulosin in medical expulsive therapy for distal ureteral stones with renal colic: a multicenter, randomized, double-blind, placebo-controlled trial. Eur Urol 2017; doi: 10.1016/j.eururo.2017.10.033. Crossref, Google Scholar 11. : Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009; 151: 264. Google Scholar 12. : Nifedipine versus tamsulosin for the management of lower ureteral stones. J Urol 2004; 172: 568. Link, Google Scholar 13. : Is there a role for tamsulosin in the treatment of distal ureteral stones of 7 mm or less? Results of a randomised, double-blind, placebo-controlled trial. Eur Urol 2009; 56: 407. Google Scholar 14. : Alpha blockers for treatment of ureteric stones: systematic review and meta-analysis. BMJ 2016; 355: i6112. Google Scholar 15. : Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet 2006; 368: 1171. Google Scholar 16. : Longitudinal stone diameter on coronal reconstruction of computed tomography as a predictor of ureteral stone expulsion in medical expulsive therapy. Urology 2012; 80: 784. Google Scholar 17. : Effect of tamsulosin on stone passage for ureteral stones: a systematic review and meta-analysis. Ann Emerg Med 2017; 69: 353. Google Scholar Supported Natural Science Foundation of China Grant 81572523, Hunan Province Funds for Distinguished Young Scientists of China Grant 2016JJ1026, the Key Research and Development Project of Hunan Provincial Science and Technology Department Grant 2016JC2041 and Fundamental Research Funds for the Central Universities of Central South University Grant 2016zzts121. © 2019 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsCited byHall M, Thiel J, Dunmire B, Samson P, Kessler R, Sunaryo P, Sweet R, Metzler I, Chang H, Gunn M, Dighe M, Anderson L, Popchoi C, Managuli R, Cunitz B, Burke B, Ding L, Gutierrez B, Liu Z, Sorensen M, Wessells H, Bailey M and Harper J (2022) First Series Using Ultrasonic Propulsion and Burst Wave Lithotripsy to Treat Ureteral StonesJournal of Urology, VOL. 208, NO. 5, (1075-1082), Online publication date: 1-Nov-2022.Stensland K, Malinconico L and Canes D (2019) Tamsulosin and Distal Ureteral Stones—How Much Evidence is Enough? Exploring Value of Information in UrologyJournal of Urology, VOL. 202, NO. 3, (465-466), Online publication date: 1-Sep-2019.Related articlesJournal of Urology8 Apr 2019Editorial CommentJournal of Urology8 Apr 2019Editorial Comment Volume 201Issue 5May 2019Page: 950-955Supplementary Materials Advertisement Copyright & Permissions© 2019 by American Urological Association Education and Research, Inc.KeywordsChinaureteral calculiurolithiasistamsulosindrug therapyMetricsAuthor Information Yu Cui Department of Urology, Xiangya Hospital, Central South University, Changsha, China Equal study contribution. More articles by this author Jinbo Chen Department of Urology, Xiangya Hospital, Central South University, Changsha, China Equal study contribution. More articles by this author Feng Zeng Department of Urology, Xiangya Hospital, Central South University, Changsha, China More articles by this author Peihua Liu Department of Urology, Xiangya Hospital, Central South University, Changsha, China More articles by this author Jiao Hu Department of Urology, Xiangya Hospital, Central South University, Changsha, China More articles by this author Huihuang Li Department of Urology, Xiangya Hospital, Central South University, Changsha, China More articles by this author Chao Li Department of Urology, Xiangya Hospital, Central South University, Changsha, China More articles by this author Xu Cheng Department of Urology, Xiangya Hospital, Central South University, Changsha, China More articles by this author Minfeng Chen Department of Urology, Xiangya Hospital, Central South University, Changsha, China More articles by this author Yangle Li Department of Urology, Xiangya Hospital, Central South University, Changsha, China More articles by this author Yang Li Department of Urology, Xiangya Hospital, Central South University, Changsha, China More articles by this author Zhongqing Yang Department of Urology, Xiangya Hospital, Central South University, Changsha, China More articles by this author Zhiyong Chen Department of Urology, Xiangya Hospital, Central South University, Changsha, China More articles by this author Harripersaud Chand Department of Urology, Xiangya Hospital, Central South University, Changsha, China More articles by this author Hequn Chen Department of Urology, Xiangya Hospital, Central South University, Changsha, China †Correspondence: Department of Urology, Xiangya Hospital, Central South University, Changsha410008, China (telephone: +86-731-8975-3011; FAX: +86-731-8975-3280; e-mail: E-mail Address: [email protected], E-mail Address: [email protected]). More articles by this author Xiongbing Zu Department of Urology, Xiangya Hospital, Central South University, Changsha, China †Correspondence: Department of Urology, Xiangya Hospital, Central South University, Changsha410008, China (telephone: +86-731-8975-3011; FAX: +86-731-8975-3280; e-mail: E-mail Address: [email protected], E-mail Address: [email protected]). More articles by this author Expand All Supported Natural Science Foundation of China Grant 81572523, Hunan Province Funds for Distinguished Young Scientists of China Grant 2016JJ1026, the Key Research and Development Project of Hunan Provincial Science and Technology Department Grant 2016JC2041 and Fundamental Research Funds for the Central Universities of Central South University Grant 2016zzts121. Advertisement PDF downloadLoading ...
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
Sharon完成签到,获得积分10
刚刚
艾云欣发布了新的文献求助10
刚刚
cuber完成签到 ,获得积分10
1秒前
Jasper应助jackycas采纳,获得10
1秒前
1秒前
nihaoya172完成签到,获得积分10
2秒前
西科Jeremy完成签到,获得积分10
2秒前
咿咿呀呀完成签到,获得积分10
2秒前
大模型应助BO采纳,获得10
3秒前
yshu完成签到,获得积分10
4秒前
丫丫发布了新的文献求助10
4秒前
置身事内应助rrr采纳,获得10
4秒前
华华爸发布了新的文献求助10
4秒前
皮卡皮卡丘完成签到,获得积分10
5秒前
Singularity发布了新的文献求助20
5秒前
5秒前
小白应助虚拟的蛋挞采纳,获得20
6秒前
苦瓜炒蛋完成签到,获得积分20
6秒前
嗖嗖完成签到 ,获得积分10
6秒前
薛枏完成签到,获得积分10
7秒前
宁霸完成签到,获得积分0
7秒前
sunyexuan完成签到,获得积分10
7秒前
990419完成签到,获得积分10
8秒前
领导范儿应助linxi采纳,获得10
8秒前
代何完成签到,获得积分10
8秒前
8秒前
8秒前
8秒前
9秒前
9秒前
10秒前
micaixing2006完成签到,获得积分10
10秒前
火锅完成签到,获得积分10
10秒前
丫丫完成签到,获得积分10
11秒前
阳光棉花糖完成签到 ,获得积分10
11秒前
wangdong应助郭菱香采纳,获得10
12秒前
Jiny完成签到,获得积分10
12秒前
饭饭完成签到,获得积分10
12秒前
xiaoxiao晓完成签到,获得积分10
13秒前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
All the Birds of the World 4000
Production Logging: Theoretical and Interpretive Elements 3000
Musculoskeletal Pain - Market Insight, Epidemiology And Market Forecast - 2034 2000
Animal Physiology 2000
Am Rande der Geschichte : mein Leben in China / Ruth Weiss 1500
CENTRAL BOOKS: A BRIEF HISTORY 1939 TO 1999 by Dave Cope 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3746429
求助须知:如何正确求助?哪些是违规求助? 3289289
关于积分的说明 10063824
捐赠科研通 3005693
什么是DOI,文献DOI怎么找? 1650347
邀请新用户注册赠送积分活动 785833
科研通“疑难数据库(出版商)”最低求助积分说明 751282